Laverock Therapeutics

Don’t invest unless you’re prepared to lose money. This is a high‑risk investment. You may not be able to access your money easily and are unlikely to be protected if something goes wrong. Take two minutes to learn more.

X

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.

Latest news

Nami Surgical appoints Nikki Palfrey as CEO and completes latest investment round
28 January 2026
Wobble Genomics shares new data confirming ability to determine profiling of HER2 in tissue and blood
06 January 2026